From AI-enabled radiology workflows to precision-led diagnostics, India’s imaging ecosystem is evolving rapidly to meet the growing demands of modern healthcare. Rising chronic disease burden, expanding healthcare access, and technological advancements are accelerating the shift toward smarter and more specialized diagnostic capabilities.
This edition of the newsletter highlights the evolving landscape of India’s diagnostic imaging market, which is increasingly shifting toward specialized and precision-driven radiology solutions. Driven by the growing burden of chronic diseases, expanding healthcare infrastructure, and rising adoption of advanced imaging technologies, diagnostic imaging is playing a more critical role in enabling early detection, clinical decision-making, and precision-led patient management across oncology, cardiology, neurology, and trauma care.
Globally, the diagnostic imaging market continues to demonstrate steady and resilient growth, projected to expand from US$ 49.0B in CY24 to US$ 60.2B by CY29P at a CAGR of 4.2%. The market remains strongly driven by rising demand for early disease detection, increasing chronic disease prevalence, aging populations, and continued advancements in high-precision imaging technologies. Mature healthcare systems across North America and Europe continue to invest in AI-enabled radiology workflows, hybrid imaging systems, and minimally invasive diagnostic capabilities, while emerging markets are contributing incremental growth through infrastructure expansion and improving healthcare accessibility. The competitive landscape remains consolidated among global medtech leaders such as GE HealthCare, Siemens Healthineers, Philips, Canon, and FUJIFILM, reflecting the high technological barriers and capital intensity associated with advanced imaging systems.
In contrast, India’s diagnostic imaging market is positioned as a faster-growing and underpenetrated opportunity, expected to grow from US$ 1.3B in FY25 to US$ 1.9B by FY30P at a CAGR of 7.8%, significantly outpacing global growth rates. The market’s acceleration is being fueled by expanding private healthcare infrastructure, rising diagnostic awareness, increasing penetration of organized diagnostic chains, and growing demand for advanced imaging across oncology, cardiology, neurology, and trauma care. India also presents a unique dual-market dynamic, where conventional imaging continues to drive accessibility and patient volumes, while advanced modalities are witnessing rising adoption across tertiary and urban healthcare centers. Additionally, the emergence of domestic manufacturers such as BPL Medical Technologies, Allengers, Trivitron Healthcare, Voxelgrids, and Panacea Medical Technologies is gradually strengthening local manufacturing capabilities and improving affordability, supporting the long-term expansion of India’s diagnostic imaging ecosystem.
India’s diagnostic imaging market is at an inflection point, where rising demand for specialized diagnostics is creating significant opportunities for technology adoption, capacity expansion, and private sector investment. The market is witnessing a gradual shift from conventional volume-driven imaging toward higher-value and precision-oriented diagnostics, particularly across oncology, cardiology, and neurology. At the same time, improving penetration into Tier II and Tier III cities is expanding the addressable market beyond metropolitan regions, creating long-term growth potential for both multinational and domestic players. However, the pace of scalable adoption will largely depend on how effectively the ecosystem addresses affordability, workforce availability, and infrastructure readiness, which continue to remain critical barriers to widespread deployment of advanced imaging technologies.
India's diagnostic imaging sector is undergoing a structural reset, one that goes beyond budget allocations and policy acronyms. The convergence of domestic manufacturing incentives, AI-led clinical deployments, and a federally-backed digital health backbone signals something more consequential: the state is no longer a passive funder but an active architect of where, how, and at what cost imaging care gets delivered. What's notable isn't any single scheme in isolation, but manufacturing self-reliance through PLI reduces upstream import dependency, while Ayushman Bharat Digital Mission builds the data rails that make AI diagnostics clinically useful rather than just commercially appealing. The real proof of concept, however, is already playing out at the state level, where Maharashtra, Karnataka, and Punjab have demonstrated that AI-assisted imaging can meaningfully close detection gaps in TB, lung cancer, and stroke, conditions where delayed diagnosis carries an outsized mortality burden. As the Union Budget accelerates investments in regional medical hubs and district hospital upgrades, the sector’s long-term success will depend on parallel improvements in workforce availability, interoperability standards, and procurement frameworks to ensure technology adoption translates into meaningful healthcare outcomes rather than utilization gaps.
